Financials data is unavailable for this security.
View more
Year on year Kronox Lab Sciences Ltd had revenues fall -5.98% from 955.78m to 898.62m, though the company grew net income 30.17% from 164.03m to 213.51m.
| Gross margin | 48.12% |
|---|---|
| Net profit margin | 23.70% |
| Operating margin | 29.97% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, Kronox Lab Sciences Ltd did not generate a significant amount of cash. However, the company earned 174.15m from its operations for a Cash Flow Margin of 19.38%. In addition the company used 173.12m on investing activities while cash flow from financing was even.
| Cash flow per share | 6.06 |
|---|---|
| Price/Cash flow per share | 29.54 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items increased 30.17%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -- |
